84-2997-35 [取扱停止]ATXN7, ID (ATXN7, SCA7, Ataxin-7, Spinocerebellar ataxia type 7 protein) (MaxLight 550) 100ul 032320-ML550

※お見積書はカートで印刷できます

冷蔵

特徴

  • MaxLight™550 is a new Yellow-Green photostable dye conjugate comparable to Alexa Fluor™546, 555, DyLight™549 , Cy3™, TRITC and offers better labeling efficiency, brighter imaging and increased immunodetection.
  • Absorbance (550nm); Emission (575nm); Extinction Coefficient 150,000.
  • The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord.
  • Clinically, ADCA has been divided into three groups: ADCA types I-III.
  • ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes.
  • ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the 'pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders.
  • Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions.
  • ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein.
  • The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations.
  • This locus has been mapped to chromosome 3, and it has been determined that the diseased allele associated with spinocerebellar ataxia-7 contains 38-130 CAG repeats (near the N-terminus), compared to 7-17 in the normal allele.
  • The encoded protein is a component of the SPT3/TAF9/GCN5 acetyltransferase (STAGA) and TBP-free TAF-containing (TFTC) chromatin remodeling complexes, and it thus plays a role in transcriptional regulation.
  • Alternative splicing results in multiple transcript variants.
  • Applications:Suitable for use in Western Blot and FLISA.
  • Other applications not tested.
  • Recommended Dilutions:Optimal dilutions to be determined by the researcher.
  • Storage and Stability:Store product at 4°C in the dark.
  • DO NOT FREEZE! Stable at 4°C for 12 months after receipt as an undiluted liquid.
  • Dilute required amount only prior to immediate use.
  • Further dilutions can be made in assay buffer.
  • Caution: MaxLight™550 conjugates are sensitive to light.
  • For maximum recovery of product, centrifuge the original vial prior to removing the cap.
  • Note: Applications are based on unconjugated antibody.

仕様

  • Size:100ul
  • Host:rabbit
  • Source Antibody:human
  • Grade:Affinity Purified
  • Purity:Purified by Protein A and peptide affinity chromatography
  • Form:Supplied as a liquid in PBS, pH 7.2. No preservative added. Labeled with MaxLight™550.
  • Specificity:Recognizes human ATXN7
  • Isotype:IgG
  • Calc Applications Abbrev:FLISA WB
  • Calc Crossreactivity:Hu
  • Immunogen:KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 354-381 in the central terminal region of human ATXN7. Species Sequence Homology: mouse
  • Shelf Life:1year
  • Swiss Prot Number:O15265
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-2997-35
型番
032320-ML550
入り数
1個
標準価格
226,000円(税抜)
WEB価格
取扱停止
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る